{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:54:21Z","timestamp":1785840861207,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T00:00:00Z","timestamp":1437350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/aps.2015.51","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T09:01:53Z","timestamp":1437382913000},"page":"1377-1387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice"],"prefix":"10.1038","volume":"36","author":[{"given":"Wei-qiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-hui","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-zhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-wen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-na","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-mao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,20]]},"reference":[{"key":"BFaps201551_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/JIR.S65979","volume":"7","author":"M Fakhoury","year":"2014","unstructured":"Fakhoury M, Negrulj R, Mooranian A, Al-Salami H . Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res 2014; 7: 113\u201320.","journal-title":"J Inflamm Res"},{"key":"BFaps201551_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.gtc.2010.08.018","volume":"39","author":"TW Lee","year":"2010","unstructured":"Lee TW, Fedorak RN . Tumor necrosis factor-alpha monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology. Gastroenterol Clin North Am 2010; 39: 543\u201357.","journal-title":"Gastroenterol Clin North Am"},{"key":"BFaps201551_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4252\/wjsc.v6.i5.526","volume":"6","author":"JD Glenn","year":"2014","unstructured":"Glenn JD, Whartenby KA . Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells 2014; 6: 526\u201339.","journal-title":"World J Stem Cells"},{"key":"BFaps201551_CR4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/ni.2406","volume":"13","author":"J Banchereau","year":"2012","unstructured":"Banchereau J, Pascual V, O'Garra A . From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol 2012; 13: 925\u201331.","journal-title":"Nat Immunol"},{"key":"BFaps201551_CR5","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/mt.2010.54","volume":"18","author":"IK Ko","year":"2010","unstructured":"Ko IK, Kim BG, Awadallah A, Mikulan J, Lin P, Letterio JJ, et al. Targeting improves MSC treatment of inflammatory bowel disease. Mol Ther 2010; 18: 1365\u201372.","journal-title":"Mol Ther"},{"key":"BFaps201551_CR6","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/stem.698","volume":"29","author":"M Duijvestein","year":"2011","unstructured":"Duijvestein M, Wildenberg ME, Welling MM, Hennink S, Molendijk I, van Zuylen VL, et al. Pretreatment with interferon-gamma enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem cells 2011; 29: 1549\u201358.","journal-title":"Stem cells"},{"key":"BFaps201551_CR7","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/MOG.0b013e328361f763","volume":"29","author":"WK van Deen","year":"2013","unstructured":"van Deen WK, Oikonomopoulos A, Hommes DW . Stem cell therapy in inflammatory bowel disease: which, when and how? Curr Opin Gastroenterol 2013; 29: 384\u201390.","journal-title":"Curr Opin Gastroenterol"},{"key":"BFaps201551_CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1684\/ecn.2011.0288","volume":"22","author":"D Boraschi","year":"2011","unstructured":"Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011; 22: 127\u201347.","journal-title":"Eur Cytokine Netw"},{"key":"BFaps201551_CR9","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.4049\/jimmunol.180.8.5477","volume":"180","author":"S Sharma","year":"2008","unstructured":"Sharma S, Kulk N, Nold MF, Graf R, Kim SH, Reinhardt D, et al. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol 2008; 180: 5477\u201382.","journal-title":"J Immunol"},{"key":"BFaps201551_CR10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA . IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010; 11: 1014\u201322.","journal-title":"Nat Immunol"},{"key":"BFaps201551_CR11","doi-asserted-by":"publisher","first-page":"16711","DOI":"10.1073\/pnas.1111982108","volume":"108","author":"EN McNamee","year":"2011","unstructured":"McNamee EN, Masterson JC, Jedlicka P, McManus M, Grenz A, Collins CB, et al. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci U S A 2011; 108: 16711\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201551_CR12","doi-asserted-by":"publisher","first-page":"15178","DOI":"10.1073\/pnas.1416714111","volume":"111","author":"Y Luo","year":"2014","unstructured":"Luo Y, Cai X, Liu S, Wang S, Nold-Petry CA, Nold MF, et al. Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc Natl Acad Sci U S A 2014; 111: 15178\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201551_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1440-1746.2012.07187.x","volume":"27","author":"N Sakai","year":"2012","unstructured":"Sakai N, Van Sweringen HL, Belizaire RM, Quillin RC, Schuster R, Blanchard J, et al. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J Gastroenterol Hepatol 2012; 27: 1609\u201316.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFaps201551_CR14","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/cei.12284","volume":"176","author":"B Wu","year":"2014","unstructured":"Wu B, Meng K, Ji Q, Cheng M, Yu K, Zhao X, et al. Interleukin-37 ameliorates myocardial ischaemia\/reperfusion injury in mice. Clin Exp Immunol 2014; 176: 438\u201351.","journal-title":"Clin Exp Immunol"},{"key":"BFaps201551_CR15","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1100\/2011\/968479","volume":"11","author":"AM Bulau","year":"2011","unstructured":"Bulau AM, Fink M, Maucksch C, Kappler R, Mayr D, Wagner K, et al. In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis. Sci World J 2011; 11: 2480\u201390.","journal-title":"Sci World J"},{"key":"BFaps201551_CR16","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.4049\/jimmunol.1300047","volume":"192","author":"X Teng","year":"2014","unstructured":"Teng X, Hu Z, Wei X, Wang Z, Guan T, Liu N, et al. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. J Immunol 2014; 192: 1815\u201323.","journal-title":"J Immunol"},{"key":"BFaps201551_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"D Rachmilewitz","year":"1989","unstructured":"Rachmilewitz D . Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 298: 82\u20136.","journal-title":"BMJ"},{"key":"BFaps201551_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJM199403243301202","volume":"330","author":"RD Pullan","year":"1994","unstructured":"Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994; 330: 811\u20135.","journal-title":"N Engl J Med"},{"key":"BFaps201551_CR19","first-page":"136329","volume":"2014","author":"Y Li","year":"2014","unstructured":"Li Y, Wang Y, Liu Y, Wang Y, Zuo X, Li Y, et al. The possible role of the novel cytokines IL-35 and IL-37 in inflammatory bowel disease. Mediators Inflamm 2014; 2014: 136329.","journal-title":"Mediators Inflamm"},{"key":"BFaps201551_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nprot.2009.238","volume":"5","author":"H Zhu","year":"2010","unstructured":"Zhu H, Guo ZK, Jiang XX, Li H, Wang XY, Yao HY, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010; 5: 550\u201360.","journal-title":"Nat Protoc"},{"key":"BFaps201551_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/aps.2015.3","volume":"36","author":"WQ Wang","year":"2015","unstructured":"Wang WQ, Zhao D, Zhou YS, Hu XY, Sun ZN, Yu G, et al. Transfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer. Acta Pharmacol Sin 2015; 36: 528\u201334.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201551_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nprot.2007.41","volume":"2","author":"S Wirtz","year":"2007","unstructured":"Wirtz S, Neufert C, Weigmann B, Neurath MF . Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007; 2: 541\u20136.","journal-title":"Nat Protoc"},{"key":"BFaps201551_CR23","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.4049\/jimmunol.178.7.4557","volume":"178","author":"P Smith","year":"2007","unstructured":"Smith P, Mangan NE, Walsh CM, Fallon RE, McKenzie AN, van Rooijen N, et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol 2007; 178: 4557\u201366.","journal-title":"J Immunol"},{"key":"BFaps201551_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1089\/hum.2009.147","volume":"21","author":"E Manning","year":"2010","unstructured":"Manning E, Pham S, Li S, Vazquez-Padron RI, Mathew J, Ruiz P, et al. Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther 2010; 21: 713\u201327.","journal-title":"Hum Gene Ther"},{"key":"BFaps201551_CR25","doi-asserted-by":"publisher","first-page":"e67790","DOI":"10.1371\/journal.pone.0067790","volume":"8","author":"Y Li","year":"2013","unstructured":"Li Y, Raman I, Du Y, Yan M, Min S, Yang J, et al. Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress. PLoS One 2013; 8: e67790.","journal-title":"PLoS One"},{"key":"BFaps201551_CR26","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2249.2008.03683.x","volume":"153","author":"JJ Choi","year":"2008","unstructured":"Choi JJ, Yoo SA, Park SJ, Kang YJ, Kim WU, Oh IH, et al. Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol 2008; 153: 269\u201376.","journal-title":"Clin Exp Immunol"},{"key":"BFaps201551_CR27","doi-asserted-by":"publisher","first-page":"e33360","DOI":"10.1371\/journal.pone.0033360","volume":"7","author":"MT Castelo-Branco","year":"2012","unstructured":"Castelo-Branco MT, Soares ID, Lopes DV, Buongusto F, Martinusso CA, do Rosario A Jr, et al. Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS One 2012; 7: e33360.","journal-title":"PLoS One"},{"key":"BFaps201551_CR28","doi-asserted-by":"publisher","first-page":"e42662","DOI":"10.1371\/journal.pone.0042662","volume":"7","author":"O Treacy","year":"2012","unstructured":"Treacy O, Ryan AE, Heinzl T, O'Flynn L, Cregg M, Wilk M, et al. Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. PLoS One 2012; 7: e42662.","journal-title":"PLoS One"},{"key":"BFaps201551_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ . How regulatory T cells work. Nat Rev Immunol 2008; 8: 523\u201332.","journal-title":"Nat Rev Immunol"},{"key":"BFaps201551_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S . Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162\u201374.","journal-title":"Nat Rev Immunol"},{"key":"BFaps201551_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1189\/jlb.0113050","volume":"94","author":"Q Guan","year":"2013","unstructured":"Guan Q, Moreno S, Qing G, Weiss CR, Lu L, Bernstein CN, et al. The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. J Leukoc Biol 2013; 94: 803\u201311.","journal-title":"J Leukoc Biol"},{"key":"BFaps201551_CR32","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ni.3103","volume":"16","author":"CA Nold-Petry","year":"2015","unstructured":"Nold-Petry CA, Lo CY, Rudloff I, Elgass KD, Li S, Gantier MP, et al. IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat Immunol 2015; 16: 354\u201365.","journal-title":"Nat Immunol"},{"key":"BFaps201551_CR33","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1073\/pnas.1424626112","volume":"112","author":"S Li","year":"2015","unstructured":"Li S, Neff CP, Barber K, Hong J, Luo Y, Azam T, et al. Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8. Proc Natl Acad Sci U S A 2015; 112: 2497\u2013502.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201551_CR34","first-page":"113","volume":"71","author":"JL Gowans","year":"1980","unstructured":"Gowans JL, Steer HW . The function and pathways of lymphocyte recirculation. Ciba Found Symp 1980; 71: 113\u201326.","journal-title":"Ciba Found Symp"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201551","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201551.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:33:18Z","timestamp":1684413198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,20]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFaps201551"],"URL":"https:\/\/doi.org\/10.1038\/aps.2015.51","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,20]]},"assertion":[{"value":"9 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}